Targeting Lactate Metabolism by Inhibiting MCT1 or MCT4 Impairs Leukemic Cell Proliferation, Induces Two Different Related Death-Pathways and Increases Chemotherapeutic Sensitivity of Acute Myeloid Leukemia Cells.

MLA

Saulle, Ernestina, et al. “Targeting Lactate Metabolism by Inhibiting MCT1 or MCT4 Impairs Leukemic Cell Proliferation, Induces Two Different Related Death-Pathways and Increases Chemotherapeutic Sensitivity of Acute Myeloid Leukemia Cells.” Frontiers in Oncology, vol. 10, Feb. 2021, p. 621458. EBSCOhost, https://doi.org/10.3389/fonc.2020.621458.

APA

Saulle, E., Spinello, I., Quaranta, M. T., Pasquini, L., Pelosi, E., Iorio, E., Castelli, G., Chirico, M., Pisanu, M. E., Ottone, T., Voso, M. T., Testa, U., & Labbaye, C. (2021). Targeting Lactate Metabolism by Inhibiting MCT1 or MCT4 Impairs Leukemic Cell Proliferation, Induces Two Different Related Death-Pathways and Increases Chemotherapeutic Sensitivity of Acute Myeloid Leukemia Cells. Frontiers in Oncology, 10, 621458. https://doi.org/10.3389/fonc.2020.621458

Chicago

Saulle, Ernestina, Isabella Spinello, Maria Teresa Quaranta, Luca Pasquini, Elvira Pelosi, Egidio Iorio, Germana Castelli, et al. 2021. “Targeting Lactate Metabolism by Inhibiting MCT1 or MCT4 Impairs Leukemic Cell Proliferation, Induces Two Different Related Death-Pathways and Increases Chemotherapeutic Sensitivity of Acute Myeloid Leukemia Cells.” Frontiers in Oncology 10 (February): 621458. doi:10.3389/fonc.2020.621458.